Septicemia in dialysis patients: Incidence, risk factors, and prognosis

被引:356
作者
Powe, NR
Jaar, B
Furth, SL
Hermann, J
Briggs, W
机构
[1] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
end-stage renal disease; sepsis; hemodialysis; peritoneal dialysis; infection; temporary vascular access; dialyzer reuse;
D O I
10.1046/j.1523-1755.1999.0550031081.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Infection is second to cardiovascular disease as a cause of death in patients with end-stage renal disease (ESRD), and septicemia causes a majority of these infectious deaths. To identify patients at high risk and to characterize modifiable risk factors for septicemia, we examined the incidence, risk factors, and prognosis for septicemia in a large, representative group of U.S. dialysis patients. Methods. We conducted a longitudinal cohort study of incident ESRD patients in the case-mix study of the U.S. Renal Data System with seven years of follow-up from hospitalization and death records. Poisson regression was used to examine independent risk factors for hospital-managed septicemia. Cox proportional hazards analysis was used to assess the independent effect of septicemia on all-cause mortality and on death from septicemia. Separate analyses were performed for patients on peritoneal dialysis (PD) and hemodialysis (HD). Results. Over seven years of follow up, 11.7% of 4005 HD patients and 9.4% of 913 PD patients had at least one episode of septicemia. Older age and diabetes were independent risk factors for septicemia in all patients. Among HD patients, low serum albumin, temporary vascular access, and dialyzer reuse were also associated with increased risk. Among PD patients, white race and having no health insurance at dialysis initiation were also risk factors. Patients with septicemia had twice the risk of death from any cause and a fivefold to ninefold increased risk of death from septicemia. Conclusions. Septicemia, which carries a marked increased risk of death, occurs frequently in patients on PD as well as HD. Early referral to a nephrologist, improving nutrition, and avoiding temporary vascular access may decrease the incidence of septicemia. Further study of how race, insurance status, and dialyzer reuse can contribute to the risk of septicemia among ESRD patients is indicated.
引用
收藏
页码:1081 / 1090
页数:10
相关论文
共 40 条
  • [1] BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329
  • [2] Bloembergen BE, 1996, ADV RENAL REPLAC THE, V3, P201
  • [3] BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231
  • [4] IRON OVERLOAD IN HEMODIALYSIS-PATIENTS INCREASES THE RISK OF BACTEREMIA - A PROSPECTIVE-STUDY
    BOELAERT, JR
    DANEELS, RF
    SCHURGERS, ML
    MATTHYS, EG
    GORDTS, BZ
    VANLANDUYT, HW
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (02) : 130 - 134
  • [5] INFECTIONS WITH MYCOBACTERIUM-CHELONEI IN PATIENTS RECEIVING DIALYSIS AND USING PROCESSED HEMODIALYZERS
    BOLAN, G
    REINGOLD, AL
    CARSON, LA
    SILCOX, VA
    WOODLEY, CL
    HAYES, PS
    HIGHTOWER, AW
    MCFARLAND, L
    BROWN, JW
    PETERSEN, NJ
    FAVERO, MS
    GOOD, RC
    BROOME, CV
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (05) : 1013 - 1019
  • [6] Carton J A, 1992, Eur J Med, V1, P281
  • [7] An evidence-based approach to earlier initiation of dialysis
    Churchill, DN
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (06) : 899 - 906
  • [8] CANADIAN HEMODIALYSIS MORBIDITY STUDY
    CHURCHILL, DN
    TAYLOR, DW
    COOK, RJ
    LAPLANTE, P
    BARRE, P
    CARTIER, P
    FAY, WP
    GOLDSTEIN, MB
    JINDAL, K
    MANDIN, H
    MCKENZIE, JK
    MUIRHEAD, N
    PARFREY, PS
    POSEN, GA
    SLAUGHTER, D
    ULAN, RA
    WERB, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) : 214 - 234
  • [9] COLLINS A, 1997, J AM SOC NEPHROL S, V8, pA231
  • [10] COLLINS A, 1997, J AM SOC NEPHROL, V8, pA230